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Abstract 
 
Poor patient compliance with peritoneal dialysis (PD) is believed to have significant adverse 
effects on renal patient morbidity and mortality, and on the resource burdens of renal health 
care services and providers. The purpose of this paper is to enhance our understanding of 
compliance in chronic renal failure and its implications for contemporary practice through a 
review of the relevant literature. Four main themes emerged in the studies examined, all of 
which indicate that PD compliance is a challenging issue and will most likely continue to be 
so in renal nursing practice. These themes include 1) the lack of a universal definition of 
compliance that is widely adopted in practice and research; 2) the need to understand and 
account for the apparently multiple and interconnected determinants of PD compliance; 3) 
the difficulties inherent in producing consensus outcome measurements of PD compliance; 
and 4) the complexity of the interventions required to produce even modest improvements in 
compliance. We conclude that compliance with peritoneal dialysis and its associated 
regimens is a multidimensional, context-bound concept, that to date has tended to efface the 
role and needs of the renal patient.  
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Introduction 
 
Peritoneal dialysis (PD) is a home-based treatment for chronic renal failure, which comprises 
a complex technical and lifestyle prescription. Health professionals argue that successful 
dialysis outcomes hinge upon the renal patient following that prescription, and note that the 
personal consequences of unsuccessful outcomes for the PD client, which include sepsis, 
cardiovascular morbidity, transfer to haemodialysis and death, also have implications for 
renal care providers and health insurers in terms of increased costs of care (Kutner, Zhang, 
McClellan, & Cole, 2002; Raj, 2002; Simpson et al., 2006). Yet PD is an intricate regimen with 
multiple aspects – compliance in this context does not relate to the dialysis procedure alone. 
Patients are asked to comply with instructions regarding numerous adjuvant medications 
such as antihypertensives, phosphate binders, vitamins, iron replacement and 
subcutaneously-administered erythropoietin and antiglycaemics. They must also adhere to 
the recommended aseptic technique, PD prescription and timing, blood glucose and blood 
pressure monitoring, diet, exercise, and attend follow-up appointments.  
 
While it is difficult to obtain robust empirical data related to PD compliance rates, there is 
good reason to believe that patient compliance with many aspects of this complicated 
regimen is poor, and can significantly undermine treatment benefits (Kutner, 2001; McDonald, 
Garg, & Haynes, 2002; Raj, 2002). This is reflected in the considerable time and energy that 
clinicians have expended in the last four decades in developing interventions to enhance the 
capacity of their patients to comply with peritoneal dialysis and the other regimens 
inseparable from it.  
 
The purpose of this paper is to enhance understanding of this issue through a review of the 
most recent research literature related to compliance with PD and the medications and other 
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procedures inherent in this treatment modality. A database search of Medline, OVID, 
CINAHL, PsycINFO and Cochrane Collaboration from the previous 10 years (1999-2008) 
was undertaken between June and August 2008. Meta-analyses, systematic reviews and 
randomised controlled trials (evidence Level I and II) were sought in the first instance. 
However, Level I and II evidence concerning compliance with specific dialysis procedures is 
limited, and because PD involves not just compliance with the dialysis technique but also 
with its many adjuvant regimens, the search necessarily extended to qualitative and 
quantitative compliance studies and literature reviews undertaken in these areas. The major 
search terms included compliance, non-compliance, adherence, concordance, peritoneal 
dialysis, home dialysis, medication and chronic illness.  
 
The literature research revealed that there is little new or useful knowledge with respect to 
compliance with dialysis procedure: there have been no systematic reviews or meta-analyses 
undertaken, although there have been several examining the related issue of medication 
adherence. Similarly, studies investigating PD compliance were at best descriptive, with no 
randomised controlled studies located.  Due to these issues, and the heterogeneity of the 
studies and reviews, it is not possible to pool the results or compare them statistically. Hence 
this paper is a review of the available data that organises and examines compliance in terms 
of four themes that have implications for future research and for the clinical practice of renal 
nurses and the care they offer people with this chronic condition. These are compliance 
definitions, compliance measurement, the factors affecting compliance, and implications of 
the available literature for nursing research and practice. The methodological approach, 
outcomes of interest and significant findings of the papers reviewed are summarised in Table 
1.  
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[Insert Table 1 about here] 
 
Defining compliance 
Research in this field is hampered by the elusive nature of compliance as a construct. It is 
one of the most voluminous, yet least understood phenomena in the body of health 
knowledge (Denhaerynck, Manhaeve, Nolte, & de Geest, 2007; Evangelista, 1999; Kyngas, Duffy, 
& Kroll, 1999; Murphy & Canales, 2001). This shortcoming is not confined to the PD literature. 
It is apparent in the compliance literature in general, with several authors reporting that up to 
fifty percent of papers describing compliance interventions fail to articulate a definition of 
compliance on which their study is based (Murphy & Canales, 2001; Vermeire, Hearnshaw, Van 
Royen, & Denekens, 2001).  
 
Adding to this problem is that the terms ‘compliance’ and ‘non-compliance’ are frequently 
used interchangeably, despite being quite different constructs (Kyngas et al., 1999; 
MacLaughlin et al., 2005; Murphy & Canales, 2001). Broadly speaking, non-compliance is the 
choice or ability not to do something, compliance is the choice or ability to do it. Yet it is 
remarkable how often non-compliance is used as a synonym for compliance (for example, 
see (Leggat, 2005; Leggat et al., 1998; Raj, 2002). Defining the positive action of compliance in 
terms of its negative, equally elusive concept in this way is an understandable, but ultimately 
unhelpful strategy on which to base rigorous research. Moreover, compliance can be 
intentional or unintentional (Vermeire et al., 2001), but it is not often differentiated in studies 
as to whether intentional or unintentional compliance has been investigated. 
 
Prior to 2000, most articulated definitions of compliance were congruent with dictionary 
definitions that emphasised ceding to the desires and demands of others; of conformity in 
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deference to the social order of things (Evangelista, 1999). Given biomedicine’s pervasive 
influence throughout all of the health professions, early and subsequent definitions of 
compliance are frequently centred in this worldview, conceiving it as the extent to which the 
patient’s behaviour coincides with medical advice (for example, see Friberg & Scherman, 
2005; Haynes, Taylor, & Sackett, 1979; MacLaughlin et al., 2005; McDonald et al., 2002; Rietveld & 
Koomen, 2002). Haynes et al’s influential definition emphasised the need for patients “to yield 
[their emphasis] to the advice of health professionals … whether declared by an autocrat, 
authoritarian clinician or developed as a consenual regimen through negotiation between a 
health professional and a citizen” (Haynes et al., 1979:1-2). To this day, many definitions of 
compliance concentrate on the biomedical rather than the behavioural or psychosocial 
processes involved. They define compliance, for example, as the amount of drug taken 
versus the amount not taken (Rietveld & Koomen, 2002; Schaffer & Yoon, 2001); the level of 
renal biochemical markers such as serum phosphate and creatinine (Kutner et al., 2002); or the 
lowering of blood pressure (Vermeire et al., 2001).  
 
Reflecting more recent debates about the patient’s role in their health care, the term 
‘adherence’ is now commonly used by those who object to the “negative and authoritative” 
(Evangelista, 1999:9) connotations of the term compliance, or to the inference that compliance 
is the sole responsibility of a passive patient who has no input into the decision (Evangelista, 
1999; MacLaughlin et al., 2005; Schaffer & Yoon, 2001). After initial resistance, the pioneers of 
compliance study, Haynes and colleagues, eventually embraced the term ‘adherence’ in 
recognition of its apparently less judgemental overtones (Haynes, McDonald, & Garg, 2002; 
McDonald et al., 2002). Hence, their formal definition has recently been amended to 
“adherence may be defined as the extent to which a patient’s behaviour (in terms of taking 
medication, following a diet, modifying habits, or attending clinics) coincides with medical 
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or health advice” (McDonald et al., 2002:1) Their amended definition, however, differs little 
from their original, except in terms of semantics; and they continue to discuss adherence 
synonymously with compliance. Furthermore, there is little consensus about the new term. 
‘Adherence’ is criticised for its perpetuation of paternalism; while its supporters argue that 
although the patient should be given more responsibility in their health care actions, those 
actions should nonetheless still be prescribed by those in a position to know better (Friberg & 
Scherman, 2005).  
 
Hence, another discipline, pharmacy, has developed a further alternative – ‘concordance’. It 
has been adopted by the Royal Pharmaceutical Society of Great Britain, who believe it 
emphasises the ultimate ethical goal of treatment rather than the processes implied in 
‘compliance’. They also prefer its overtones of agreement and harmony between an 
empathetic professional and the patient as decision-maker (Vermeire et al., 2001). 
Concordance implies that the patient and the prescriber collaborate actively to create and 
implement a therapeutic regimen recommended, rather than prescribed by the health expert 
(Friberg & Scherman, 2005). It has not, however, been widely embraced among pharmacists or 
the other health disciplines (Loghman-Adham, 2003), for irrespective of disciplinary 
affiliattion, ‘compliance’ remains the most commonly used term in the health literature 
(Carpenter, 2005). 
 
Nephrology nurses’ views of compliance, adherence and concordance tend to reflect 
nursing’s general discomfort with the reductionist, moralistic implications of all of these 
terms and definitions (Murphy & Canales, 2001; Costaninini 2006; Russell, Daly, Hughes, & op't 
Hoog, 2003). More recently, nephrology nurses have moved away from such definitions 
altogether, preferring the notions of self-care or self-management (Burrows-Hudson & 
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Prowant, 2005). While these concepts are still evolving, and continue to recognise that 
something called ‘compliance’ may exist, such notions emphasise the patient as an active 
partner in their treatment, possessing the “knowledge and skills to care for themselves, 
making decisions about their care; identifying problems; setting goals; and monitoring and 
managing symptoms” (White, 2004:388). It is argued that the notion of self-management is 
more useful than compliance because it is the client, after all, who self-manages the required 
PD regimen in their home, not the clinician (White, 2004).  
 
A thorough review of the literature nonetheless demonstrates that irrespective of notions of 
patient inclusiveness embedded in these alternative notions of adherence and self-
management, there is still one perspective missing here: that of the patient. While the 
enormous body of work in this area demonstrates compliance in all its permutations is a 
priority for renal health professionals, we do not know whether it is viewed in the same way 
by renal patients. In the course of this review, no research was located that defined or 
explored compliance from the patient’s perspective.   
 
Measuring compliance 
There is currently no widely-accepted gold standard for the measurement of compliance in 
any area of chronic disease, mainly because the lack of a consensus definition makes it 
difficult to operationalise and then quantify compliance in a standardised way (Denhaerynck 
et al., 2007; Mattke et al., 2007). As a result, the heterogenous outcome measures in the myriad 
studies undertaken to date are not amenable to the pooling and meta-analysis that would 
allow comparison of their efficacy (Bennett & Glazsiou, 2003; Connor, Rafter, & Rodgers, 2004; 
Higgins & Regan, 2004; Murphy & Canales, 2001; Schroeder, Fahey, & Ebrahim.S., 2004; Takiya, 
Peterson, & Finley, 2004). Nonetheless, in the PD context it is possible to categorise two broad 
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areas that are often measured: 1) compliance with adjuvant medications and 2) compliance 
with specific dialysis techniques.  
 
Compliance with adjuvant medications 
Measurements of medication compliance can be direct or indirect. Indirect measures are 
often biochemical metabolites or markers detected in a body fluid. For example, some 
studies have measured serum levels of low density lipoprotein cholesterol (Lee, Grace, & 
Taylor, 2006) and some have measured urine drug levels (Vermeire et al., 2001). Other indirect 
biophysiological measures include blood pressure monitoring (Lee et al., 2006). These 
measures have been criticised, however, as they are not available for all of the relevant 
medications and cannot account for the individual pharmacokinetic variances of drugs and of 
the people who take them (Vermeire et al., 2001). Nor can they account for the time of day at 
which the sample was drawn or measured (MacLaughlin et al., 2005) or the methods patients 
have developed to avoid the detection of undesirable biophysiological markers (Anonymised, 
2007; Anonymised, 2010).  
 
Direct measures of medication compliance are also varied. For example, Mattke et al 
developed measures that quantified prescription fill rates, the time elapsed between obtaining 
prescriptions, and the amount of medication possessed by the patient over a prescribed length 
of time (Mattke et al., 2007). Similarly, the main outcome measure in assessing medication 
adherence in one recent prospective randomised controlled trial was a change in the 
proportion of pills taken by patients compared to baseline (Lee et al., 2006). The limitation of 
these measures is that they may overestimate true rates of compliance, because obtaining 
medications and taking medications are two different things (MacLaughlin et al., 2005). Other 
researchers quantify apparent pill ingestion and express it as a percentage to measure 
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compliance rates. Hence in one study, if a patient was prescribed an antibiotic to be taken as 
1 tablet 4 times per week, but took only 2 tablets per day for 5 days, the adherence rate was 
calculated at 36% (10/28) (McDonald et al., 2002). In a similar vein, one randomised 
controlled trial calculated drug compliance scores as the number of drugs that the patient was 
fully compliant with, divided by the total number of prescribed drugs, expressed as a 
percentage (Wu et al., 2007). None of these ‘objective’ methods for assessing medication 
compliance are considered completely reliable (MacLaughlin et al., 2005; Vermeire et al., 2001). 
They are criticised because direct questioning of patients may provide unreliable data, 
particularly if close-ended questions or those with judgemental overtones are used 
(MacLaughlin et al., 2005).  
 
Compliance with PD techniques 
With respect to the measurement of other aspects of the PD regimen, compliance with 
aseptic technique; dialysate dose, timing and frequency; catheter exit site care; and diet and 
fluid restrictions are all considered important indicators. Again a variety of direct and 
indirect measures have been used to assess these. These include patient self reports, 
observational checklists, observer subjective reports, attendance rates at clinics, 
hospitalisation rates, quality of life surveys, interdialytic weight gains; and shortening or 
skipping of dialysis sessions. These have all been utilised with varying degrees of success 
(Chow et al., 2007; Vlaminck et al., 2001; White, 2004). Similarly, electronic monitoring systems 
using computer chips in home dialysis machines (Sevick et al., 1999); and quantifying the 
supply of dialysate ordered by the patient (Bernardini, Nagy, & Piraino, 2000; Figueiredo, 
Santos, & Cruetzberg, 2005) have enabled the frequency and quantity of dialysate use to be 
determined – but not who is actually using it or how they are doing so. Moreover, none of 
these benchmarks can account for the intention to comply in situations where confounding 
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factors beyond the patient’s control, such as technical problems with the PD machine, thwart 
their efforts (Anonymised paper, 2010).  
 
Factors affecting PD compliance  
Just as there is no adequate definition of PD compliance, there is little understanding of the 
factors that might contribute to it. Several authors note that predictors of compliance may be 
different for people over the age of 65, as they may have age-specific barriers to compliance 
(such as co-morbidities that impair cognition, sight and hearing) that consequently make 
them more vulnerable to the incorrect use of renal medication (Higgins & Regan, 2004; 
MacLaughlin et al., 2005; van Eijken, Tsang, Wensing, de Smet, & Grol, 2003). Demographics 
have also been investigated, but have demonstrated only a tenuous relationship between 
medication adherence and factors such as socioeconomic status, gender or marital status 
(Schaffer & Yoon, 2001; Vermeire et al., 2001). Peritoneal dialysis and its associated regimens 
are costly, life-long treatments. It is known that compliance rates are lower in similarly 
chronic illnesses if the treatment is longstanding, inconvenient to lifestyle, entails a high 
number and cost of medications, or it attempts to manage concurrent asymptomatic 
conditions such as hypertension (Holley & De Vore, 2006; Lee et al., 2006; Loghman-Adham, 
2003; Vermeire et al., 2001). Conversely, good rates of compliance are reported in patients 
who are disabled or incarcerated, or whose costs are contained, due to higher incidences of 
community responsibility and supervision (Anonymised, 2009).  
 
Complex social determinants may be the most influential of all the factors related to 
compliance. For example, patients’ own knowledge, coping styles and experiences, as well 
as those of family members and friends, are among the few variables demonstrated as 
associated with compliance in chronic diseases such as renal failure (Christensen, 2000; 
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Vermeire et al., 2001). It is unfortunate that many renal patients are prejudged by clinicians as 
unable to comply by the very nature of their perceived neglect of the conditions (such as 
diabetes and hypertension) that led to their renal failure. White (2004:1), for example, argues 
that by the time “a typical patient reaches end-stage renal disease … an individual pattern of 
nonadherence has been developed and refined for over 50 years”. Other authors are less 
morally-inclined, noting that while more than 200 separate socially-mediated variables 
hypothesised to influence compliance with medication have been studied, none of them can 
be used individually to reliably predict it (Vermeire et al., 2001). It is increasingly recognised 
that compliance behaviour cannot be understood by taking any of these variables in isolation, 
as they are usually mutually influential, and can perhaps only be understood from a complex 
systems perspective (Rietveld & Koomen, 2002).  
 
Interventions to improve compliance 
The interventions tested to enhance compliance are as various as the indicators used to 
measure it. These interventions fall into four broad categories: educational strategies; 
practical aids; simplification of the regimen; and a combination of one or more of these. 
Education is one of the most consistently and rigorously tested. For example, one recent 
randomised controlled trial involving 502 chronically ill subjects investigated the effect on 
medication compliance of periodic telephone education by a pharmacist, with a resulting 
reported improvement in medication compliance (Wu et al., 2007). Similarly, Mattke et al 
(2007) undertook a pre-post test intervention with 24,943 patients to improve medication 
compliance. After first identifying the patients’ potential for compliance through predictive 
modelling, those less likely to comply received regular personalised education and advice 
from a call-centre based nurse. The lowest risk patients were given access to information 
from a range of internet, call centre and print resources regarding their disease (Mattke et al., 
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2007). However, unlike Wu et al’s (2007) study and despite the considerable resources 
expended, the investigators concluded that the intervention had only a modest effect that was 
neither clinically or statistically significant (Mattke et al., 2007).  
 
In terms of practical aids to compliance, renal patients may have peripheral neuropathies, 
digital amputations and decreased visual acuity as a result of the diabetes that often instigates 
their renal failure. Hence interventions designed to overcome such functional challenges to 
seeing and opening medication bottles may be worth considering. While one study found that 
pictorial as opposed to traditional labelling was not effective; simplifying the instructions of 
medications that require multiple daily doses appeared to reduce the risk of patient 
misinterpretation (MacLaughlin et al., 2005). In other words, rather than prescribe a drug 
‘every 6 hours’, the investigators suggested that labelling a bottle ‘three times daily’ or with 
the specific time of day minimised incorrect self-administration (MacLaughlin et al., 2005). 
Fixed-dose combination pills and unit-of-use packaging designed to simplify medication 
regimens and by implication, enhance medication compliance in chronic illnesses, have been 
tried repeatedly. A systematic review of these strategies concluded that the limitations of the 
available evidence meant that their clinical efficacy was not able to be determined (Connor et 
al., 2004) 
 
Simplying regimens is the third category of intervention. In a systematic review of 
randomised controlled trials conducted between 1975 and 2000, which aimed to improve 
antihypertensive medication compliance, the authors concluded that a reduction in the 
number of daily doses appeared to be effective in increasing adherence as a first time 
strategy (Schroeder et al., 2004). An earlier meta-analysis of studies investigating the 
relationship between patient adherence and antihypertensive drug dosing frequency similarly 
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concluded that compliance with a once-daily dose was significantly higher than for multiple-
daily or twice-daily dosing (Iskedjian et al., 2002). A review of interventions to enhance clinic 
attendance noted that simplifying procedures such as patient-initiated appointments, shorter 
intervals between referral and appointment, shorter clinic waiting times and prepayment 
were all effective in improving patient compliance with appointments (Vermeire et al., 2001). 
 
It has been argued that the most successful strategies comprise a combination of these three 
categories of intervention, because multifaceted approaches are posited as addressing a more 
comprehensive range of compliance barriers (Ogedegbe & Schoenthaler, 2006; Schroeder et al., 
2004; Takiya et al., 2004; van Eijken et al., 2003). However, the present examination elicited 
little evidence to support complex multimodal interventions in the long term. For example, 
Higgins and Regan systematically reviewed the effectiveness of interventions to enhance the 
compliance of older people with their medication regimens, most of which involved a 
combination of external cognitive supports and educational interventions (Higgins & Regan, 
2004). Few of these had clinically significant effects and their findings support other meta-
analyses that concluded there was little evidence to support one type of compliance 
intervention over another (Haynes et al., 2002; Higgins & Regan, 2004; MacLaughlin et al., 2005; 
McDonald et al., 2002). A more recent systematic review of all randomised controlled studies 
to enhance medication adherence in chronic conditions, undertaken between 1967 and 2004, 
found that informational, behavourial and social interventions undertaken alone or in 
combination may improve medication adherence, but were not likely to affect clinical 
outcomes (Kripilani, Yao, & Haynes, 2007). One of the significant deficits in all intervention 
studies, no matter how successful, is that they provide limited information about their 
apparently considerable human, financial and material resource implications (Beswick et al., 
2005). 
Compliance and peritoneal dialysis: Lessons from the literature 
Page 15 of 23 
 
Implications for nursing practice and research 
Four main issues arise from this review. First, there is currently little consensus on how to 
define compliance, particularly as it relates to PD, which makes it difficult to operationalise 
the concept in a rigorous or meaningful way. This contributes to the second challenge 
apparent in the literature: in the absence of an operationisable definition, it is difficult to 
develop valid and reliable measures of compliance with any aspect of PD regimens. Third, 
despite these challenges, numerous interventions based on the vaguest notion of PD 
compliance have been developed to improve it, with varying success. Fourth, compliance 
appears to be a result of multiple determinants in all domains of health; hence some 
approaches to this issue have tried to account for these by developing complex ‘bundled’ 
interventions. Again, these have reported mixed outcomes with generally only modest 
improvements in compliance. They are not likely to enhance it in the PD context.  
 
This literature review has made it apparent that compliance is a multidimensional, context-
bound concept, involving numerous perspectives, procedures and levels of measurement. It 
is the synergy of these factors that probably influences whether a person wants to comply 
with all or part of their PD regimen; or indeed, if they are able to. Yet there is one 
perspective missing here: that of the patient. While the enormous body of work in this area 
demonstrates compliance is a priority for renal health professionals, we do not know whether 
it is viewed in the same way by renal patients.  
 
People generally seek treatment approaches that are manageable, tolerable and effective for 
their situation; hence they may not necessarily view all of the treatments recommended as in 
their best interests (Friberg & Scherman, 2005; Vermeire et al., 2001). Yet all that we know 
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about PD compliance has issued from health professionals, not patients. It may be worth 
bearing in mind that ‘compliance’ is a judgement by health professionals laden with a range 
of lifestyle assumptions, implicit moral codes and other judgements of worth. In PD, these 
judgements are concerned with measuring and correcting acceptable ways to care for the 
self, standards of personal cleanliness, levels of intelligence, frugal use of material and 
economic resources, and other criteria that determine who should and should not be allowed 
to self manage their renal failure with this home-based therapy. As a consequence, renal 
compliance incorporates a range of factors which, from the client perspective, may not be the 
concern of the health professions at all and which they may believe renal clinicians have no 
business in promoting.  
 
Regimens such as PD “fulfill theoretical, physiological, and empirical considerations about 
optimal care, while ignoring practical patient-centred concerns, such as the nature, nurture, 
culture, and stereotyping of the patient, and the inconvenience, cost, and adverse effects of 
the treatment” (McDonald et al., 2002:1). We simply do not know how important compliance 
is to PD patients, or whether there are other outcomes that are more desirable for them. What 
we do know is that patients do not blindly follow professional advice but negotiate their PD 
therapy into their lifestyle to enable them to live with their renal failure in the way that best 
suits them (Anonymised, 2007, In review; Polaschek, 2007).  
 
Conclusion 
The implications of this review for research into PD compliance or for those who practise 
PD nursing are two-fold. First, robust research into PD compliance means revisiting the 
basics. It would be useful if each investigation established an unambiguous definition and a 
sound theoretical basis for its use of the term ‘compliance’ and its variants. Without these 
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tools, there are very few options with respect to operationalising or measuring the concept in 
a practical or meaningful way. Because PD compliance is a mutable entity, involving an 
array of medication, procedure and lifestyle choices, it is unreasonable to expect that every 
researcher arrive at the same definition or employ the same theoretical framework across 
diverse contexts. However, a definition and theoretical framework suitable to the context 
should be articulated in each investigation from the outset, and remain a constant guide for 
action within that project.  It could be reasonably argued that this consistent lack of 
conceptual clarity on which to base research has contributed to the current paucity of Level I 
and II evidence with respect to PD compliance. Second, PD compliance is complex. It means 
different things to different people, particularly to different patients. Moreover, most 
successful compliance strategies in areas other than PD are those that make life easier and 
simpler for patients.  It is therefore essential for researchers and practitioners to make every 
effort to understand how patients understand compliance, and how it might complicate their 
specific situation. Given the inherent complexity and flexibility of the notion of PD 
compliance, care should be exercised in applying the concept to patients in a blanket fashion, 
who should not be burdened with the unconscious value judgements of health professionals. 
It is relatively easy to dichotomise patients as ‘compliant’, ‘non-compliant’, ‘adherent’ or 
‘non-adherent’; but it is not so easy for patients to carry these labels, particularly when they 
have not been self-determined.  
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Table 1: Papers reviewed for this review, ranked by level of evidence and date 
 
Type of 
study/paper 
Date Author/s Outcome of interest Conclusions 
Meta-analysis 2004 Takiya et al  Pooled 16 RCTs using 
interventions to enhance 
adherence to antihypertensives 
from 1970-2000.  
Interventions varied and study groups 
non-homogenous. No single 
intervention improves adherence over 
others. Suggest a patient-specific 
intervention approach be modelled. 
Meta analysis 2002 Iskedjian et al Relationship between daily dose 
frequency and adherence to 
antihypertensive medication, 8 
studies pooled 
With antihypertensive regimens, once-
daily dosing schedules are associated 
with higher rates of adherence than 
twice daily or multiple dosing 
schedules. 
Systematic review 2008 McDonald et al Patient adherence to medication 
prescriptions. All RCTs 
published between 1967 and 
2001reporting interventions to 
improve medication adherence 
in the elderly. 33 studies 
assessed 
Studies too disparate to warrant meta-
analysis. Current methods for 
improving medication adherence are 
‘complex, labor-intensive, and not 
predictably effective’. 
Systematic review 2007 Kripalani et al RCTs published between Jan 
1967 and Sept 2004 reporting 
unconfounded interventions 
intended to enhance medication 
adherence with self-
administered medications in 
chronic medical conditions, 39 
studies assessed  
Adherence increased with behavioural 
interventions that reduced dosing 
demands or involved monitoring and 
feedback; involved multisession 
information or combined intervention. 
Several interventions may be effective 
in improving adherence in chronic 
medical conditions, but few 
significantly affect clinical outcomes. 
Systematic review 2006 Ogedegbe and 
Schoenthaler 
11 RCTs reviewed for effects of 
home blood pressure monitoring 
on medication adherence 
Complex interventions report more 
statistically significant improvements 
in adherence; interventions conducted 
in hospital and home settings more 
successful than those in primary care 
settings.  
Systematic review 2004 Connor et al Studied 15 trials investigating 
role of fixed dose combination 
pills and unit of use packaging 
in promoting medication 
adherence 
Note a trend towards improved 
adherence that was statistically or 
clinically significant; however 
outcome measures were heterogenous 
and studies limited by small sample 
sizes. 
Systematic review 2004 Higgins and Regan Review of RCTs between 1966-
2002 studying effectiveness of 
interventions for improving 
medication compliance in the 
elderly. 7 studies assessed. 
Studies too heterogenous to compare; 
used variety of behavioural and social 
interventions that had little statistical 
or clinical effects. No strong evidence 
to support any one intervention type. 
Systematic review 2004 Schroeder et al Improvement of adherence to 
anti-hypertensive medication in 
ambulatory care, 38 RCTs 
undertaken between 1975 and 
2000 assessed 
Results not pooled due to 
heterogeneity of studies. More 
successful strategies are reducing the 
number of daily doses, with 
motivational and complex strategies 
more promising.  
Systematic review 2003 Van Eijken et al Improving medication 
compliance amongst older 
community dwellers, 14 RCTs 
reviewed 
Telephone-linked interventions 
achieved ‘the most striking effect’, 
with multifaceted and tailored 
interventions resulting in more 
favourable compliance rates 
Randomised 2007 Wu et al Telephone intervention to Drug compliance defined as taking 80-
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controlled trial enhance compliance (n = 506) 120% of prescribed daily dose. Main 
outcome measure = all cause 
mortality. Telephone counselling 
associated with 41% reduction in the 
risk of death (RR 0.59; 95% CI; 0.35-
0.97; p = 0.0039); patients receiving 
polypharmacy, poor compliance 
associated with increased mortality.  
Randomised 
controlled trial 
2006 Lee et al Effect of pharmacy care 
program on medication 
adherence (n= 200) 
Intervention increased medication 
adherence to 96.9% (5.2%; p < 0.001) 
6 months post intervention 
Prospective 
observational 
2007 Chow et al Adherence with PD, measured 
by late arrival for PD training 
and subsequent peritonitis (n = 
159) 
Late arrival in >20% of PD training 
sessions associated with >50% 
increased likelihood of subsequent 
peritonitis. RR 1.56 (95% CI; 1.02-
2.39; p = 0.04).  
Non-randomised, 
pre-test/post-test 
intervention study 
2007 Mattke et al Effect of disease management 
program on medication 
compliance, measured by 
prescription fill rates, 
medication possession ratio and 
length of gap between refills (n 
= 24,943) 
Different ways to operationalise 
compliance can lead to ‘fundamentally 
different conclusions’ in measurement 
methods 
Longitudinal, 
prospective, 
observational, 
descriptive 
2000 Bernadini et al Noncompliance with PD, 
defined as performance of less 
than 90% of prescribed PD 
exchanges (n = 92) 
72% consistently compliant, 2% 
consistently noncompliant, 15% 
noncompliant at beginning of PD but 
became compliant at follow up, 11% 
intermittently noncompliant. 
Recommend a home visit during 1st 6 
months to determine compliance.  
Descriptive survey 2006 Holly and DeVore Medication compliance dialysis 
patients (PD and haemo: n = 54) 
Inadequate prescription coverage, lack 
of transportation, medication cost are 
primary contributors to medication 
noncompliance. 
Descriptive, 
telephone self-
report by patients  
2005 Figeuiredo et al Compliance measured by PD 
supply inventories.  Patients 
performing at least 90% of 
prescribed exchanges considered 
compliant (n = 30). 
Patients who first treatment choice 
was PD were more likely to be 
compliant than patients for whom PD 
was not the first choice (74% vs 64% 
compliance), hence participation in the 
decision-making process improves 
compliance  
Multicentre, cross-
sectional, self-report 
survey 
2001 Vlaminck et al Construct and criterion validity  
of Dialysis Diet and Fluid Non-
Adherence Questionnaire 
(DDFQ) in Flanders (n = 564) 
Suggest that DDFQ is valid self-report 
instrument to assess non-adherence 
behaviour haemodialysis patients in 
Flanders 
Descriptive, 
observation of 
behaviours 
1999 Sevick et al PD adherence, measured by self-
reported daily logs and 
electronic monitoring of dialysis 
fluid use (n = 20) 
Significant disparities found between 
self- and computer monitored reports 
 
Critical interpretive 2007 Polaschek Attitude of home dialysis 
patients to therapy and 
adherence (n = 20) 
Many variables affect compliance, and 
understanding these variables may 
help improve outcomes 
Literature review 2007 Denhaerynck et al Prevalence and consequences of 
non-adherence to haemodialysis 
prescriptions 
Inconsistencies in definitions and 
invalid measurement methods hamper 
research.  
Literature review of 
concept 
 
2005 Carpenter Relationship of concept of 
perceived threat to treatment 
adherence  
Little consistency in operationalising 
‘perceived threat’ relating to treatment 
adherence, nor incorporation of  
personal and contextual patient factors 
Literature review 2005 MacLaughlin et al Assessing medication adherence Personal and contextual factors 
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in the elderly influence medication adherence. 
Traditional methods for measuring 
adherence are unreliable. 
Literature review 2003 Loghman-Adham Compliance in renal disease Suggests simplifying treatment 
regimen, establishing a partnership 
with client and increasing patient 
awareness through education and 
feedback to improve compliance 
Literature review 2002 Raj Compliance with PD Reviews predictors, consequences, 
methods to identify and monitor. 
Concludes noncompliance should be 
managed by patient education and 
therapy modification. 
Literature review 2002 Rietveld and 
Koomen 
The effect of complex systems 
on medication compliance 
Knowledge, illness beliefs, symptom 
perception, anxiety, symptom self-
efficacy, medication self-efficacy, 
social support and patient/health 
professional congruence are variables 
that mutually influence medication 
compliance. 
Literature review 2001 Kutner  Compliance with dialysis Further study required into 
psychosocial determinants, 
compliance behaviour patterns over 
time, and parameters in which 
compliance can vary and still remain 
safe 
Literature review of 
concept  
2000 Kyngas et al Compliance No agreement on definition or 
measurement 
Concept analysis  1999 Evangelista Compliance  Patient should be viewed as active 
participants in health care and more 
understanding of patient perspective of 
compliance required  
Literature review 2001 Schaffer and Yoon Medication adherence Classifies adherence interventions into 
affective, behavioural and cognitive 
domains. 
Literature review 2001 Vermeire et al Patient adherence to treatment Research hampered by failure to 
define ‘adherence’. Further research 
required.  
Discussion paper 2006 Costanini Compliance, adherence and self 
management in chronic kidney 
disease patients 
Compliance and adherence poorly 
understood in this population. Patient 
perspectives need to be accounted for, 
and ‘self-management’ is promising as 
a conceptual basis for improving 
outcomes 
Discussion paper 2005 Friberg and 
Scherman 
Compliance Understanding of the teaching and 
learning components of compliance, 
and understanding patients’ 
perspectives,  is essential 
Discussion paper 2004 White Adherence to dialysis 
prescription 
Patient-centred approaches that 
removal barriers to adherence and 
provide education and cognitive 
behavioural strategies my improve 
adherence outcomes. 
Discussion paper 2003 Russell et al Non compliance A patient-centred approach necessary 
to enhance compliance 
Discussion paper 2001 Murphy and 
Beanland 
Definition of compliance from 
nursing perspective 
Advocate an ‘emancipatory ’ 
definition on which to base further 
nursing research 
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